{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T13:35:01Z","timestamp":1776173701707,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences & Health Services","doi-asserted-by":"crossref","award":["97-02-30-38692"],"award-info":[{"award-number":["97-02-30-38692"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10310-y","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T06:26:03Z","timestamp":1738736763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and characteristics of ST131-O16 and ST131-O25b clones among extended-spectrum \u03b2-lactamase-producing Escherichia coli isolates causing bloodstream infection in Iran"],"prefix":"10.1007","volume":"52","author":[{"given":"Mohammad Taha","family":"Ebrahimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3963-4225","authenticated-orcid":false,"given":"Shahnaz","family":"Halimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2408-1736","authenticated-orcid":false,"given":"Maryam","family":"Yavari-Bafghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3417-4482","authenticated-orcid":false,"given":"Reza","family":"Beigverdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein Ali","family":"Rahdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0208-7264","authenticated-orcid":false,"given":"Mohammad","family":"Emaneini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7205-8269","authenticated-orcid":false,"given":"Fereshteh","family":"Jabalameli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"10310_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/cid\/ciab005","volume":"73","author":"E Begier","year":"2021","unstructured":"Begier E, Rosenthal NA, Gurtman A et al (2021) Epidemiology of Invasive Escherichia coli infection and antibiotic resistance status among patients treated in US hospitals: 2009\u20132016. Clin Infect Dis 73:565\u2013574. https:\/\/doi.org\/10.1093\/cid\/ciab005","journal-title":"Clin Infect Dis"},{"key":"10310_CR2","doi-asserted-by":"publisher","unstructured":"Sora VM, Meroni G, Martino PA et al (2021) Extraintestinal pathogenic escherichia coli: virulence factors and antibiotic resistance. Pathogens 10. https:\/\/doi.org\/10.3390\/pathogens10111355","DOI":"10.3390\/pathogens10111355"},{"key":"10310_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12223-019-00719-x","volume":"65","author":"P Behzadi","year":"2020","unstructured":"Behzadi P (2020) Classical chaperone-usher (CU) adhesive fimbriome: uropathogenic Escherichia coli (UPEC) and urinary tract infections (UTIs). Folia Microbiol (Praha) 65:45\u201365","journal-title":"Folia Microbiol (Praha)"},{"key":"10310_CR4","doi-asserted-by":"publisher","unstructured":"Manges AR, Geum HM, Guo A et al (2019) Global extraintestinal pathogenic escherichia coli (Expec) lineages. Clin Microbiol Rev 32. https:\/\/doi.org\/10.1128\/CMR.00135-18","DOI":"10.1128\/CMR.00135-18"},{"key":"10310_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jhin.2018.07.033","volume":"101","author":"JA Otter","year":"2019","unstructured":"Otter JA, Galletly TJ, Davies F et al (2019) Planning to halve Gram-negative bloodstream infection: getting to grips with healthcare-associated Escherichia coli bloodstream infection sources. J Hosp Infect 101:129\u2013133. https:\/\/doi.org\/10.1016\/j.jhin.2018.07.033","journal-title":"J Hosp Infect"},{"key":"10310_CR6","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1093\/cid\/ciab560","volume":"73","author":"KS Kaye","year":"2021","unstructured":"Kaye KS, Gupta V, Mulgirigama A et al (2021) Antimicrobial Resistance trends in urine Escherichia coli isolates from adult and adolescent females in the United States from 2011 to 2019: rising ESBL strains and impact on Patient Management. Clin Infect Dis 73:1992\u20131999. https:\/\/doi.org\/10.1093\/cid\/ciab560","journal-title":"Clin Infect Dis"},{"key":"10310_CR7","doi-asserted-by":"publisher","unstructured":"Algammal A, Hetta HF, Mabrok M, Behzadi P (2023) Editorial: emerging multidrug-resistant bacterial pathogens superbugs: a rising public health threat. Front Microbiol 14:1135614. https:\/\/doi.org\/10.3389\/fmicb.2023.1135614","DOI":"10.3389\/fmicb.2023.1135614"},{"key":"10310_CR8","doi-asserted-by":"publisher","unstructured":"Forde BM, Roberts LW, Phan MD et al (2019) Population dynamics of an Escherichia coli ST131 lineage during recurrent urinary tract infection. Nat Commun 10. https:\/\/doi.org\/10.1038\/s41467-019-11571-5","DOI":"10.1038\/s41467-019-11571-5"},{"key":"10310_CR9","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1089\/mdr.2019.0312","volume":"26","author":"A Jafari","year":"2020","unstructured":"Jafari A, Falahatkar S, Delpasand K et al (2020) Emergence of Escherichia coli ST131 causing urinary tract infection in Western Asia: a systematic review and Meta-analysis. Microb Drug Resist 26:1357\u20131364. https:\/\/doi.org\/10.1089\/mdr.2019.0312","journal-title":"Microb Drug Resist"},{"key":"10310_CR10","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/S1473-3099(18)30353-0","volume":"18","author":"KD Vihta","year":"2018","unstructured":"Vihta KD, Stoesser N, Llewelyn MJ et al (2018) Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998\u20132016: a study of electronic health records. Lancet Infect Dis 18:1138\u20131149. https:\/\/doi.org\/10.1016\/S1473-3099(18)30353-0","journal-title":"Lancet Infect Dis"},{"key":"10310_CR11","doi-asserted-by":"publisher","unstructured":"Naylor NR, Pouwels KB, Hope R et al (2019) The health and cost burden of antibiotic resistant and susceptible Escherichia coli bacteraemia in the English hospital setting: a national retrospective cohort study. PLoS ONE 14. https:\/\/doi.org\/10.1371\/journal.pone.0221944","DOI":"10.1371\/journal.pone.0221944"},{"key":"10310_CR12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jhin.2018.10.024","volume":"101","author":"O Blandy","year":"2019","unstructured":"Blandy O, Honeyford K, Gharbi M et al (2019) Factors that impact on the burden of Escherichia coli bacteraemia: multivariable regression analysis of 2011\u20132015 data from West London. J Hosp Infect 101:120\u2013128. https:\/\/doi.org\/10.1016\/j.jhin.2018.10.024","journal-title":"J Hosp Infect"},{"key":"10310_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3201\/eid1402.070350","volume":"14","author":"TM Coque","year":"2008","unstructured":"Coque TM, Novais \u00c2, Carattoli A et al (2008) Dissemination of clonally related Escherichia coli strains expressing extended-spectrum \u03b2-Lactamase CTX-M-15. Emerg Infect Dis 14:195\u2013200. https:\/\/doi.org\/10.3201\/eid1402.070350","journal-title":"Emerg Infect Dis"},{"key":"10310_CR14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1089\/mdr.2014.0261","volume":"21","author":"SY Cho","year":"2015","unstructured":"Cho SY, Kang C-I, Cha MK et al (2015) Clinical features and treatment outcomes of Bloodstream infections caused by extended-spectrum \u03b2-Lactamase-producing Escherichia coli sequence type 131. Microb Drug Resist 21:463\u2013469. https:\/\/doi.org\/10.1089\/mdr.2014.0261","journal-title":"Microb Drug Resist"},{"key":"10310_CR15","unstructured":"(2015) Bailey & Scott\u2019s Diagnostic Microbiology, 15th Edition"},{"key":"10310_CR16","unstructured":"Clinical (2024) and Laboratory Standards Institue (CLSI)"},{"key":"10310_CR17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB et al (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268\u2013281. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x","journal-title":"Clin Microbiol Infect"},{"key":"10310_CR18","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1128\/JCM.01468-12","volume":"50","author":"M Doumith","year":"2012","unstructured":"Doumith M, Day MJ, Hope R et al (2012) Improved multiplex PCR strategy for rapid assignment of the four major Escherichia coli phylogenetic groups. J Clin Microbiol 50:3108\u20133110. https:\/\/doi.org\/10.1128\/JCM.01468-12","journal-title":"J Clin Microbiol"},{"key":"10310_CR19","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1128\/JCM.02562-14","volume":"53","author":"M Doumith","year":"2015","unstructured":"Doumith M, Day M, Ciesielczuk H et al (2015) Rapid identification of major Escherichia coli sequence types causing urinary tract and bloodstream infections. J Clin Microbiol 53:160\u2013166. https:\/\/doi.org\/10.1128\/JCM.02562-14","journal-title":"J Clin Microbiol"},{"key":"10310_CR20","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1128\/JCM.03502-13","volume":"52","author":"JR Johnson","year":"2014","unstructured":"Johnson JR, Clermont O, Johnston B et al (2014) Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131. J Clin Microbiol 52:1358\u20131365. https:\/\/doi.org\/10.1128\/JCM.03502-13","journal-title":"J Clin Microbiol"},{"key":"10310_CR21","doi-asserted-by":"publisher","unstructured":"Hyun M, Lee JY, Kim Hah (2021) Differences of virulence factors, and antimicrobial susceptibility according to phylogenetic group in uropathogenic Escherichia coli strains isolated from Korean patients. Ann Clin Microbiol Antimicrob 20. https:\/\/doi.org\/10.1186\/s12941-021-00481-4","DOI":"10.1186\/s12941-021-00481-4"},{"key":"10310_CR22","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1128\/JCM.01555-13","volume":"51","author":"J Blanco","year":"2013","unstructured":"Blanco J, Mora A, Mamani R et al (2013) Four main virotypes among extended-spectrum-\u03b2-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics. J Clin Microbiol 51:3358\u20133367. https:\/\/doi.org\/10.1128\/JCM.01555-13","journal-title":"J Clin Microbiol"},{"key":"10310_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2010.12.002","volume":"70","author":"L Poirel","year":"2011","unstructured":"Poirel L, Walsh TR, Cuvillier V, Nordmann P (2011) Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 70:119\u2013123. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2010.12.002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10310_CR24","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1128\/JCM.02038-12","volume":"50","author":"CN Geyer","year":"2012","unstructured":"Geyer CN, Reisbig MD, Hanson ND (2012) Development of a TaqMan multiplex PCR assay for detection of plasmid-mediated AmpC \u03b2-lactamase genes. J Clin Microbiol 50:3722\u20133725. https:\/\/doi.org\/10.1128\/JCM.02038-12","journal-title":"J Clin Microbiol"},{"key":"10310_CR25","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.2147\/IDR.S400170","volume":"16","author":"R Li","year":"2023","unstructured":"Li R, Xu H, Tang H et al (2023) The characteristics of extended-spectrum \u03b2-Lactamases (ESBLs)-Producing Escherichia coli in Bloodstream infection. Infect Drug Resist 16:2043\u20132060. https:\/\/doi.org\/10.2147\/IDR.S400170","journal-title":"Infect Drug Resist"},{"key":"10310_CR26","doi-asserted-by":"publisher","unstructured":"Komatsu Y, Kasahara K, Inoue T et al (2018) Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan. PLoS ONE 13. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0202276","DOI":"10.1371\/JOURNAL.PONE.0202276"},{"key":"10310_CR27","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1093\/jac\/dkac071","volume":"77","author":"E Jauneikaite","year":"2022","unstructured":"Jauneikaite E, Honeyford K, Blandy O et al (2022) Bacterial genotypic and patient risk factors for adverse outcomes in Escherichia coli bloodstream infections: a prospective molecular epidemiological study. J Antimicrob Chemother 77:1753\u20131761. https:\/\/doi.org\/10.1093\/jac\/dkac071","journal-title":"J Antimicrob Chemother"},{"key":"10310_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1469-0691.2012.03762.x","volume":"19","author":"Y Matsumura","year":"2013","unstructured":"Matsumura Y, Nagao M, Iguchi M et al (2013) Molecular and clinical characterization of plasmid-mediated AmpC \u03b2-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum \u03b2-lactamase-producing and non-resistant E. Coli bacteraemia. Clin Microbiol Infect 19:161\u2013168. https:\/\/doi.org\/10.1111\/j.1469-0691.2012.03762.x","journal-title":"Clin Microbiol Infect"},{"key":"10310_CR29","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.2169\/internalmedicine.56.7702","volume":"56","author":"H Namikawa","year":"2017","unstructured":"Namikawa H, Yamada K, Fujimoto H et al (2017) Clinical characteristics of bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli at a tertiary hospital. Intern Med 56:1807\u20131815. https:\/\/doi.org\/10.2169\/internalmedicine.56.7702","journal-title":"Intern Med"},{"key":"10310_CR30","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1093\/ofid\/ofz004","volume":"6","author":"RE Mendes","year":"2019","unstructured":"Mendes RE, Jones RN, Woosley LN et al (2019) Application of next-generation sequencing for characterization of surveillance and clinical trial isolates: analysis of the distribution of \u03b2-lactamase resistance genes and lineage background in the United States. Open Forum Infect Dis 6:S69\u2013S78. https:\/\/doi.org\/10.1093\/ofid\/ofz004","journal-title":"Open Forum Infect Dis"},{"key":"10310_CR31","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1089\/mdr.2016.0272","volume":"23","author":"MH Namaei","year":"2017","unstructured":"Namaei MH, Yousefi M, Ziaee M et al (2017) First Report of Prevalence of CTX-M-15-Producing Escherichia coli O25b\/ST131 from Iran. Microb Drug Resist 23:879\u2013884. https:\/\/doi.org\/10.1089\/mdr.2016.0272","journal-title":"Microb Drug Resist"},{"key":"10310_CR32","doi-asserted-by":"publisher","unstructured":"Hojabri Z, Darabi N, Arab M et al (2019) Clonal diversity, virulence genes content and subclone status of Escherichia coli sequence type 131: comparative analysis of E. Coli ST131 and non-ST131 isolates from Iran. BMC Microbiol 19. https:\/\/doi.org\/10.1186\/s12866-019-1493-8","DOI":"10.1186\/s12866-019-1493-8"},{"key":"10310_CR33","doi-asserted-by":"publisher","unstructured":"Brumwell A, Sutton G, Lantos PM et al (2023) Escherichia coli ST131 Associated with increased mortality in bloodstream infections from urinary tract source. J Clin Microbiol 61. https:\/\/doi.org\/10.1128\/jcm.00199-23","DOI":"10.1128\/jcm.00199-23"},{"key":"10310_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-022-00526-2","author":"A Khoshbayan","year":"2022","unstructured":"Khoshbayan A, Golmoradi Zadeh R, Taati Moghadam M et al (2022) Molecular determination of O25b\/ST131 clone type among extended spectrum \u03b2-lactamases production Escherichia coli recovering from urinary tract infection isolates. Ann Clin Microbiol Antimicrob. https:\/\/doi.org\/10.1186\/s12941-022-00526-2. 21:","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10310_CR35","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.jmii.2019.03.005","volume":"52","author":"WT Hung","year":"2019","unstructured":"Hung WT, Cheng MF, Tseng FC et al (2019) Bloodstream infection with extended-spectrum beta-lactamase\u2013producing Escherichia coli: the role of virulence genes. J Microbiol Immunol Infect 52:947\u2013955. https:\/\/doi.org\/10.1016\/j.jmii.2019.03.005","journal-title":"J Microbiol Immunol Infect"},{"key":"10310_CR36","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1128\/AAC.01025-12","volume":"57","author":"S Adams-Sapper","year":"2013","unstructured":"Adams-Sapper S, Diep BA, Perdreau-Remington F, Riley LW (2013) Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections. Antimicrob Agents Chemother 57:490\u2013497. https:\/\/doi.org\/10.1128\/AAC.01025-12","journal-title":"Antimicrob Agents Chemother"},{"key":"10310_CR37","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1128\/AAC.05753-11","volume":"56","author":"HC Chung","year":"2012","unstructured":"Chung HC, Lai CH, Lin JN et al (2012) Bacteremia caused by extended-spectrum-\u03b2-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality. Antimicrob Agents Chemother 56:618\u2013622. https:\/\/doi.org\/10.1128\/AAC.05753-11","journal-title":"Antimicrob Agents Chemother"},{"key":"10310_CR38","doi-asserted-by":"publisher","unstructured":"Shaik S, Ranjan A, Tiwari SK et al (2017) Comparative genomic analysis of globally dominant ST131 clone with other epidemiologically successful extraintestinal pathogenic escherichia coli (ExPEC) lineages. https:\/\/doi.org\/10.1128\/mBio.01596-17. MBio 8:","DOI":"10.1128\/mBio.01596-17"},{"key":"10310_CR39","doi-asserted-by":"publisher","unstructured":"Zhong Y, Liu W, Meng Q et al (2019) Escherichia coli O25b-ST131 and O16-ST131 causing urinary tract infection in women in Changsha, China: molecular epidemiology and clinical characteristics. Taylor Fr Zhong, WE Liu, Q Meng, Y LiInfection drug Resist 2019\u2022Taylor Fr 12:2693\u20132702. https:\/\/doi.org\/10.2147\/IDR.S212658","DOI":"10.2147\/IDR.S212658"},{"key":"10310_CR40","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.jksus.2019.11.043","volume":"32","author":"A Alqasim","year":"2020","unstructured":"Alqasim A, Abu Jaffal A, Almutairi N et al (2020) Isolation, phenotypic and genotypic characterization of Escherichia coli from the bloodstream samples in Riyadh, Saudi Arabia. J King Saud Univ - Sci 32:1464\u20131469. https:\/\/doi.org\/10.1016\/j.jksus.2019.11.043","journal-title":"J King Saud Univ - Sci"},{"key":"10310_CR41","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1089\/mdr.2019.0485","volume":"27","author":"M Rasoulinasab","year":"2021","unstructured":"Rasoulinasab M, Shahcheraghi F, Feizabadi MM et al (2021) Distribution of pathogenicity island markers and H-Antigen types of Escherichia coli O25b\/ST131 isolates from patients with urinary tract infection in Iran. Microb Drug Resist 27:369\u2013382. https:\/\/doi.org\/10.1089\/mdr.2019.0485","journal-title":"Microb Drug Resist"},{"key":"10310_CR42","doi-asserted-by":"publisher","unstructured":"Shahbazi R, Salmanzadeh-Ahrabi S, Aslani MM et al (2023) The genotypic and phenotypic characteristics contributing to high virulence and antibiotics resistance in Escherichia coli O25-B2-ST131 in comparison to non- O25-B2-ST131. https:\/\/doi.org\/10.1186\/s12887-023-03866-w. BMC Pediatr 23:","DOI":"10.1186\/s12887-023-03866-w"},{"key":"10310_CR43","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/jac\/dkx466","volume":"73","author":"PNA Harris","year":"2018","unstructured":"Harris PNA, Ben Zakour NL, Roberts LW et al (2018) Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27. J Antimicrob Chemother 73:634\u2013642. https:\/\/doi.org\/10.1093\/jac\/dkx466","journal-title":"J Antimicrob Chemother"},{"key":"10310_CR44","doi-asserted-by":"publisher","first-page":"390","DOI":"10.24171\/j.phrp.2021.0272","volume":"12","author":"N Jomehzadeh","year":"2021","unstructured":"Jomehzadeh N, Ahmadi K, Rahmani Z (2021) Prevalence of plasmid-mediated AmpC \u03b2-lactamases among uropathogenic Escherichia coli isolates in southwestern Iran. Osong Public Heal Res Perspect 12:390\u2013395. https:\/\/doi.org\/10.24171\/j.phrp.2021.0272","journal-title":"Osong Public Heal Res Perspect"},{"key":"10310_CR45","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1128\/AAC.00638-12","volume":"56","author":"D Morris","year":"2012","unstructured":"Morris D, McGarry E, Cotter M et al (2012) Detection of OXA-48 carbapenemase in the pandemic clone Escherichia coli O25b:H4-ST131 in the course of investigation of an outbreak of OXA-48-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 56:4030\u20134031","journal-title":"Antimicrob Agents Chemother"},{"key":"10310_CR46","doi-asserted-by":"publisher","unstructured":"Mora A, Blanco M, L\u00f3pez C et al (2011) Emergence of clonal groups O1:HNM-D-ST59, O15:H1-D-ST393, O20:H34\/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain. Int J Antimicrob Agents 37:16\u201321. https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.09.012","DOI":"10.1016\/j.ijantimicag.2010.09.012"},{"key":"10310_CR47","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1128\/AAC.05824-11","volume":"56","author":"JR Johnson","year":"2012","unstructured":"Johnson JR, Urban C, Weissman SJ et al (2012) Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and bla CTX-M-15among extended-spectrum-\u03b2- lactamase-producing E. Coli from the United States, 2000 to 2009. Antimicrob Agents Chemother 56:2364\u20132370. https:\/\/doi.org\/10.1128\/AAC.05824-11","journal-title":"Antimicrob Agents Chemother"},{"key":"10310_CR48","doi-asserted-by":"publisher","unstructured":"Lavigne JP, Vergunst AC, Goret L et al (2012) Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131. PLoS ONE 7. https:\/\/doi.org\/10.1371\/journal.pone.0034294","DOI":"10.1371\/journal.pone.0034294"},{"key":"10310_CR49","doi-asserted-by":"publisher","unstructured":"Friedrich R, Rappold E, Bogdan C, Held J (2018) Comparative analysis of the wako \u0392-glucan test and the fungitell assay for diagnosis of candidemia and pneumocystis jirovecii pneumonia. J Clin Microbiol 56. https:\/\/doi.org\/10.1128\/JCM","DOI":"10.1128\/JCM"},{"key":"10310_CR50","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.diagmicrobio.2011.12.011","volume":"72","author":"AK Van der Bij","year":"2012","unstructured":"Van der Bij AK, Peirano G, Pitondo-Silva A, Pitout JDD (2012) The presence of genes encoding for different virulence factors in clonally related Escherichia coli that produce CTX-Ms. Diagn Microbiol Infect Dis 72:297\u2013302. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2011.12.011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10310_CR51","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1086\/653932","volume":"51","author":"JR Johnson","year":"2010","unstructured":"Johnson JR, Johnston B, Clabots C et al (2010) Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistaColi. coli infections in the United States. Clin Infect Dis 51:286\u2013294. https:\/\/doi.org\/10.1086\/653932","journal-title":"Clin Infect Dis"},{"key":"10310_CR52","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/jac\/dkm464","volume":"61","author":"MH Nicolas-Chanoine","year":"2008","unstructured":"Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V et al (2008) Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 61:273\u2013281. https:\/\/doi.org\/10.1093\/jac\/dkm464","journal-title":"J Antimicrob Chemother"},{"key":"10310_CR53","doi-asserted-by":"publisher","first-page":"175","DOI":"10.4103\/bbrj.bbrj_270_21","volume":"6","author":"N Jomehzadeh","year":"2022","unstructured":"Jomehzadeh N, Ahmadi K, Nasiri Z (2022) Evaluation of biofilm formation and antibiotic resistance pattern in extended-spectrum \u03b2-lactamase-producing escherichia coli strains. Biomed Biotechnol Res J 6:175\u2013179. https:\/\/doi.org\/10.4103\/bbrj.bbrj_270_21","journal-title":"Biomed Biotechnol Res J"},{"key":"10310_CR54","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1099\/jmm.0.000224","volume":"65","author":"F Can","year":"2016","unstructured":"Can F, Kurt-Azap O, Nurtop E et al (2016) Molecular epidemiology of bloodstreamassociated escherichia coli ST131 H30-Rx subclone infection in a region with high quinolone resistance. J Med Microbiol 65:306\u2013310. https:\/\/doi.org\/10.1099\/jmm.0.000224","journal-title":"J Med Microbiol"},{"key":"10310_CR55","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1086\/315217","volume":"181","author":"JR Johnson","year":"2000","unstructured":"Johnson JR, Stell AL (2000) Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 181:261\u2013272. https:\/\/doi.org\/10.1086\/315217","journal-title":"J Infect Dis"},{"key":"10310_CR56","doi-asserted-by":"publisher","first-page":"5694","DOI":"10.1073\/pnas.1322678111","volume":"111","author":"NK Petty","year":"2014","unstructured":"Petty NK, Zakour NLB, Stanton-Cook M et al (2014) Global dissemination of a multidrug resistant Escherichia coli clone. Proc Natl Acad Sci U S A 111:5694\u20135699. https:\/\/doi.org\/10.1073\/pnas.1322678111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10310_CR57","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.ijmm.2014.10.002","volume":"304","author":"G Dahbi","year":"2014","unstructured":"Dahbi G, Mora A, Mamani R et al (2014) Molecular epidemiology and virulence of Escherichia coli O16: H5-ST131: comparison with H30 and H30-Rx subclones of O25b: H4-ST131. Int J Med Microbiol 304:1247\u20131257. https:\/\/doi.org\/10.1016\/j.ijmm.2014.10.002","journal-title":"Int J Med Microbiol"},{"key":"10310_CR58","doi-asserted-by":"publisher","first-page":"6385","DOI":"10.1128\/AAC.01604-13","volume":"57","author":"R Banerjee","year":"2013","unstructured":"Banerjee R, Robicsek A, Kuskowski MA et al (2013) Molecular epidemiology of Escherichia coli sequence type 131 and its H30 and H30-Rx subclones among extended-Spectrum-\u03b2-Lactamase-positive and -negative E. Coli Clinical isolates from the Chicago Region, 2007 to 2010. Antimicrob Agents Chemother 57:6385\u20136388. https:\/\/doi.org\/10.1128\/AAC.01604-13","journal-title":"Antimicrob Agents Chemother"},{"key":"10310_CR59","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/jac\/dkq491","volume":"66","author":"A Coelho","year":"2011","unstructured":"Coelho A, Mora A, Mamani R et al (2011) Spread of Escherichia coli O25b:H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain). J Antimicrob Chemother 66:517\u2013526. https:\/\/doi.org\/10.1093\/jac\/dkq491","journal-title":"J Antimicrob Chemother"},{"key":"10310_CR60","doi-asserted-by":"publisher","unstructured":"Bayatinejad G, Salehi M, Beigverdi R et al (2023) In Vitro antibiotic combinations of Colistin, Meropenem, Amikacin, and Amoxicillin\/clavulanate against multidrug-resistant Klebsiella pneumonia isolated from patients with ventilator-associated pneumonia. BMC Microbiol 23. https:\/\/doi.org\/10.1186\/s12866-023-03039-w","DOI":"10.1186\/s12866-023-03039-w"},{"key":"10310_CR61","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12941-021-00481-4","volume":"20","author":"M Hyun","year":"2021","unstructured":"Hyun M, Lee JY, Kim Hah (2021) Differences of virulence factors, and antimicrobial susceptibility according to phylogenetic group in uropathogenic Escherichia coli strains isolated from Korean patients. Ann Clin Microbiol Antimicrob 20:77. https:\/\/doi.org\/10.1186\/s12941-021-00481-4","journal-title":"Ann Clin Microbiol Antimicrob"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10310-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10310-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10310-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:25:09Z","timestamp":1766852709000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10310-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10310"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10310-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"3 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received approval from the Ethics Committee of Tehran University of Medical Sciences, Tehran, Iran, under code IR.TUMS.MEDICINE.REC.1397.256. Sampling and data collection adhered to the committee\u2019s oversight, and informed consent was considered unnecessary according to committee regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All the authors agreed with the publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"206"}}